ARTMS is a developer of technology that transforms the production of diagnostic imaging isotopes.. Founded in 2013, ARTMS is backed by investors that include GF Securities, Quark Venture, Deerfield Management, and Global health sciences venture fund and is headquartered in Vancouver.